These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 31531420)

  • 1. Functional analyses of a low-penetrance risk variant rs6702619/1p21.2 associating with colorectal cancer in Polish population.
    Statkiewicz M; Maryan N; Kulecka M; Kuklinska U; Ostrowski J; Mikula M
    Acta Biochim Pol; 2019 Sep; 66(3):329-336. PubMed ID: 31531420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci.
    Niittymäki I; Tuupanen S; Li Y; Järvinen H; Mecklin JP; Tomlinson IP; Houlston RS; Karhu A; Aaltonen LA
    BMC Med Genet; 2011 Feb; 12():23. PubMed ID: 21314996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1.
    Biancolella M; Fortini BK; Tring S; Plummer SJ; Mendoza-Fandino GA; Hartiala J; Hitchler MJ; Yan C; Schumacher FR; Conti DV; Edlund CK; Noushmehr H; Coetzee SG; Bresalier RS; Ahnen DJ; Barry EL; Berman BP; Rice JC; Coetzee GA; Casey G
    Hum Mol Genet; 2014 Apr; 23(8):2198-209. PubMed ID: 24256810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of GNAS mutation in colorectal carcinogenesis.
    Lee H; La BM; Hwang I; Kang YN; Choi IJ; Lee JH
    Tumori; 2017 Mar; 103(2):209-211. PubMed ID: 26350188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic landscapes suggest that genetic risk for intracranial aneurysm operates on the endothelium.
    Poppenberg KE; Jiang K; Tso MK; Snyder KV; Siddiqui AH; Kolega J; Jarvis JN; Meng H; Tutino VM
    BMC Med Genomics; 2019 Oct; 12(1):149. PubMed ID: 31666072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
    Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
    Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
    [No Abstract]   [Full Text] [Related]  

  • 7. A functional variant in the boundary of a topological association domain is associated with pancreatic cancer risk.
    Mei S; Ke J; Tian J; Ying P; Yang N; Wang X; Zou D; Peng X; Yang Y; Zhu Y; Gong Y; Zhong R; Chang J; Miao X
    Mol Carcinog; 2019 Oct; 58(10):1855-1862. PubMed ID: 31237042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese genome-wide association study identifies a significant colorectal cancer susceptibility locus at chromosome 10p14.
    Takahashi Y; Sugimachi K; Yamamoto K; Niida A; Shimamura T; Sato T; Watanabe M; Tanaka J; Kudo S; Sugihara K; Hase K; Kusunoki M; Yamada K; Shimada Y; Moriya Y; Suzuki Y; Miyano S; Mori M; Mimori K
    Cancer Sci; 2017 Nov; 108(11):2239-2247. PubMed ID: 28869801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide association study identified copy number variants associated with sporadic colorectal cancer risk.
    Thean LF; Low YS; Lo M; Teo YY; Koh WP; Yuan JM; Chew MH; Tang CL; Cheah PY
    J Med Genet; 2018 Mar; 55(3):181-188. PubMed ID: 29079706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant activation of CYR61 enhancers in colorectal cancer development.
    Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
    J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
    Banday MZ; Sameer AS; Chowdri NA; Haq E
    Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of eleven common, low-penetrance colorectal cancer susceptibility genetic variants at six risk loci with clinical outcome.
    Hoskins JM; Ong PS; Keku TO; Galanko JA; Martin CF; Coleman CA; Wolfe M; Sandler RS; McLeod HL
    PLoS One; 2012; 7(7):e41954. PubMed ID: 22848671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.
    Middeldorp A; Jagmohan-Changur S; van Eijk R; Tops C; Devilee P; Vasen HF; Hes FJ; Houlston R; Tomlinson I; Houwing-Duistermaat JJ; Wijnen JT; Morreau H; van Wezel T
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3062-7. PubMed ID: 19843678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a Potential Regulatory Variant for Colorectal Cancer Risk Mapping to Chromosome 5q31.1: A Post-GWAS Study.
    Ke J; Lou J; Chen X; Li J; Liu C; Gong Y; Yang Y; Zhu Y; Zhang Y; Gong J
    PLoS One; 2015; 10(9):e0138478. PubMed ID: 26381143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of liver tissue identify functional gene regulatory elements associated to gene expression, type 2 diabetes, and other metabolic diseases.
    Cavalli M; Baltzer N; Pan G; Bárcenas Walls JR; Smolinska Garbulowska K; Kumar C; Skrtic S; Komorowski J; Wadelius C
    Hum Genomics; 2019 Apr; 13(1):20. PubMed ID: 31036066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer.
    Whiffin N; Dobbins SE; Hosking FJ; Palles C; Tenesa A; Wang Y; Farrington SM; Jones AM; Broderick P; Campbell H; Newcomb PA; Casey G; Conti DV; Schumacher F; Gallinger S; Lindor NM; Hopper J; Jenkins M; Dunlop MG; Tomlinson IP; Houlston RS
    Hum Mol Genet; 2013 Dec; 22(24):5075-82. PubMed ID: 23904454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Colorectal cancer susceptibility genetic variants in tumor free and colorectal carcinoma bearing Hungarian population. Individual predisposition to cancer].
    Szentirmay Z; Kurcsics J; Csernák E; Tándor I; Tóth E
    Orv Hetil; 2018 Oct; 159(40):1614-1623. PubMed ID: 30277414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H.
    Pittman AM; Naranjo S; Jalava SE; Twiss P; Ma Y; Olver B; Lloyd A; Vijayakrishnan J; Qureshi M; Broderick P; van Wezel T; Morreau H; Tuupanen S; Aaltonen LA; Alonso ME; Manzanares M; Gavilán A; Visakorpi T; Gómez-Skarmeta JL; Houlston RS
    PLoS Genet; 2010 Sep; 6(9):e1001126. PubMed ID: 20862326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNPs in microRNA-binding sites in the ITGB1 and ITGB3 3'-UTR increase colorectal cancer risk.
    Ye P; Li Z; Jiang H; Liu T
    Cell Biochem Biophys; 2014 Sep; 70(1):601-7. PubMed ID: 24777809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.